BeStock  
Stocks › Biotechnology › ALNY

Alnylam Pharmaceuticals ALNY

US equityMarket cap rank #427Biotechnology
$236.54 −$10.20 (-4.13%)
Market open · Oct 1, 1:20 pm ET · After hours $246.74 0.00%
Open$248.21
Prev close$246.74
Day range$233.53 – $251.71
Volume868.2K
Market cap$31.65B
P/E (TTM)41.2
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership101.7%-0.44 pts vs. prior quarter
Institutions holding1,005-3 vs. prior quarter

The five largest holders on file together own 44.7% of shares outstanding.

Largest holders

  • Capital Research15.71%
  • FMR10.66%
  • BlackRock8.15%
  • Vanguard Capital Management, LLC5.15%
  • T. Rowe Price Group, Inc.5.08%
  • Vanguard Portfolio Management, LLC4.89%
  • Invesco Capital Management LLC2.73%
  • State Street Global Advisors2.66%

By investor type

  • Mutual Fund87.65%
  • Hedge Fund5.72%
  • Public Company2.90%
  • Sovereign Wealth Fund1.89%
  • Government Pension Fund1.53%
  • Private Company0.80%
  • VC/PE Fund0.77%
  • Individual/Insider0.39%

No ownership data on file for this stock.

Discussion

No comments yet — be the first to weigh in on ALNY.

Leave a comment

Scroll to Top